{"id":"ethinyl-estradiol-dienogest","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-15","effect":"Breakthrough bleeding"},{"rate":"2-5","effect":"Mood changes"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ethinyl estradiol is a synthetic estrogen that inhibits follicle-stimulating hormone (FSH) secretion, while dienogest is a progestin that suppresses luteinizing hormone (LH) and increases cervical mucus viscosity. Together, they prevent ovulation and create an unfavorable environment for sperm transport and implantation, providing contraceptive efficacy.","oneSentence":"Ethinyl estradiol and dienogest work together as a combined oral contraceptive, suppressing ovulation through hormonal feedback on the hypothalamic-pituitary-ovarian axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:45:55.731Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"},{"name":"Treatment of endometriosis-associated pain"}]},"trialDetails":[{"nctId":"NCT06396208","phase":"NA","title":"\"Quick-starting\" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2024-05-01","conditions":"Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile","enrollment":40},{"nctId":"NCT02636972","phase":"","title":"The Progression From Dysmenorrhoea to Chronic Pelvic Pain","status":"COMPLETED","sponsor":"University of Adelaide","startDate":"2014-11","conditions":"Dysmenorrhoea, Pelvic Pain, Chronic Pain","enrollment":56},{"nctId":"NCT06145438","phase":"PHASE3","title":"Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2023-09-04","conditions":"Endometriosis Ovary","enrollment":80},{"nctId":"NCT00754065","phase":"PHASE3","title":"To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-09-08","conditions":"Contraception","enrollment":409},{"nctId":"NCT06577974","phase":"NA","title":"Role of Medical Treatment in Endometriosis Patients Undergoing ICSI","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Endometriosis","enrollment":129},{"nctId":"NCT02400801","phase":"NA","title":"Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-06","conditions":"Endometriosis, Infertility","enrollment":166},{"nctId":"NCT06316206","phase":"PHASE4","title":"The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2023-01-01","conditions":"Endometrial Polyp, Endometrial Diseases","enrollment":80},{"nctId":"NCT06324851","phase":"PHASE4","title":"The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2023-01-01","conditions":"Endometrial Polyp, Endometrial Diseases","enrollment":150},{"nctId":"NCT03945513","phase":"PHASE3","title":"A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2019-12-03","conditions":"Contraception","enrollment":1034},{"nctId":"NCT02352090","phase":"PHASE4","title":"Synthetic vs Natural Estrogen in Combined Oral Contraception","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2015-04-01","conditions":"Contraception","enrollment":59},{"nctId":"NCT00280657","phase":"PHASE3","title":"Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03-10","conditions":"Acne Vulgaris","enrollment":1326},{"nctId":"NCT04256200","phase":"PHASE2, PHASE3","title":"Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2017-02-07","conditions":"Endometriosis","enrollment":100},{"nctId":"NCT03890042","phase":"NA","title":"Dienogest for Treatment of Adenomyotic Uteri","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-03-01","conditions":"Adenomyosis","enrollment":100},{"nctId":"NCT01266408","phase":"","title":"INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2010-11-22","conditions":"Contraception","enrollment":82921},{"nctId":"NCT03353857","phase":"PHASE1","title":"Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-11-29","conditions":"Biological Availability","enrollment":68},{"nctId":"NCT01600274","phase":"NA","title":"Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest","status":"COMPLETED","sponsor":"Pharbil Waltrop GmbH","startDate":"2010-01","conditions":"Focus: Bioequivalence","enrollment":20},{"nctId":"NCT04193852","phase":"PHASE1","title":"Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2019-11-09","conditions":"Bioequivalence","enrollment":10},{"nctId":"NCT03172533","phase":"PHASE2","title":"Estrogen Replacement in Anorexia Nervosa","status":"TERMINATED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2016-03-15","conditions":"Anorexia Nervosa","enrollment":11},{"nctId":"NCT03124524","phase":"PHASE4","title":"Treatment Choice in Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Adana Numune Training and Research Hospital","startDate":"2015-01-15","conditions":"Primary Dysmenorrhea","enrollment":99},{"nctId":"NCT02599077","phase":"PHASE2, PHASE3","title":"Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas","status":"SUSPENDED","sponsor":"Fundación Santa Fe de Bogota","startDate":"2015-11","conditions":"Endometriosis","enrollment":50},{"nctId":"NCT01697111","phase":"PHASE3","title":"Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-10","conditions":"Endometriosis","enrollment":312},{"nctId":"NCT00778609","phase":"PHASE3","title":"Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-12","conditions":"Oral Contraceptive, Headache, Pelvic Pain","enrollment":449},{"nctId":"NCT00909857","phase":"PHASE3","title":"Effect on Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-04","conditions":"Primary Dysmenorrhea","enrollment":507},{"nctId":"NCT02385448","phase":"PHASE4","title":"Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2015-02","conditions":"Endometriosis","enrollment":144},{"nctId":"NCT00764881","phase":"PHASE3","title":"Effects of SH T00658ID on Libido","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-01","conditions":"Contraception, Libido","enrollment":217},{"nctId":"NCT00471991","phase":"PHASE2","title":"Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-04","conditions":"Oral Contraceptive","enrollment":60},{"nctId":"NCT00302666","phase":"PHASE3","title":"Bleeding Pattern Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-06","conditions":"Oral Contraceptive","enrollment":1315}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"UTERINE HAEMORRHAGE"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Valette, ATC code G03AA"],"phase":"marketed","status":"active","brandName":"Ethinyl estradiol / dienogest","genericName":"Ethinyl estradiol / dienogest","companyName":"Helsinki University Central Hospital","companyId":"helsinki-university-central-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethinyl estradiol and dienogest work together as a combined oral contraceptive, suppressing ovulation through hormonal feedback on the hypothalamic-pituitary-ovarian axis. Used for Contraception, Treatment of endometriosis-associated pain.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}